GE Healthcare partners with Volpara; U.S. Army and Helius update CRADA;

@FierceMedDev: ICYMI: Researchers develop needle-free temporary tattoo for glucose monitoring. Article | Follow @FierceMedDev

@VarunSaxena2: Piramal buys Coldstream - The HinduMore | Follow @VarunSaxena2

@EmilyWFierce: Carmat notches a win as artificial heart patient returns home. More | Follow @EmilyWFierce

> GE Healthcare ($GE) has partnered with Volpara Solutions to distribute its dense breast cancer screening tools. Financial terms of the deal were undisclosed. Release

> The U.S. Army and Helius Medical Technologies modified their 2013 Cooperative Research and Development Agreement (CRADA) to help speed the development of a noninvasive brain stimulation device that is being developed for the treatment of balance disorder in patients with mild-to-moderate traumatic brain injury. Release

> FEops, which creates patient-specific 3-D simulations for cardiovascular interventions, got a €1.3 million Series A financing round, led by Capricorn Venture Partners and PMV. Its first product, TAVIguide, is a cloud-based preoperative planning service for transcatheter aortic valve implantation. Release

> Gecko BioMedical got a €1.3 million from Bpifrance to support the development of its biodegradable surgical glues and patches for wound closure. Release

Biotech News

@FierceBiotech: ICYMI: Exclusive: Constellation chops staff, plots go-it-alone strategy as Genentech option deadline looms. Report | Follow @FierceBiotech

@JohnCFierce: Alzheimer's investigators open a new front in BACE1 war. More from FierceBiotechResearch | Follow @JohnCFierce

@DamianFierce: A CF patient taking 's Kalydeco will be a guest of Michelle Obama at the State of the Union tonight. More | Follow @DamianFierce

> Actavis, Richter tout new PhIII data for their tarnished schizophrenia drug. Article

> CytRx surges after FDA lifts a partial hold on late-stage cancer drug. Story

Pharma News

@FiercePharma: MSF urges GSK, Pfizer to slash pneumococcal vaccine prices. Report from FierceVaccines | Follow @FiercePharma

@CarlyHFierce: ICYMI: Actavis working to add Allergan CEO Pyott to board: Reuters. Story | Follow @CarlyHFierce

> J&J's pharma unit 'fastest-growing' in the drug business, CEO Gorsky says. Report

> GlaxoSmithKline rejected e-cig buy to beef up stop-smoking franchise. Article

Biotech IT News

> Personalis raises $33M to scale up pharma-facing genomics operation. Report

> 10X Genomics exits stealth mode with $80M, plan to improve Illumina tech. News

> Novartis teams with Qualcomm on $100M digital health fund. Item

> Genentech teams with Venter's HLI as Roche group continues genomics push. Story

> 23andMe inks Pfizer deal, eyes 2015 resolution of FDA dispute. Article

CRO News

> Clinipace banks $50M to scout for more deals. Story

> Evotec strikes an R&D deal focused on addiction. More

> AMRI inks a 10-year NIH deal with $37M on the line. News

> Ergomed posts a big year with more in store for 2015. Article

> Sanofi taps Catalent for antibody R&D. Report

Animal Health News

> Annual sales of animal health products stable at $7.5B. Item

> China bans import of U.S. poultry products on avian flu fear. Report

> Microbiome dealmaking hits animal health with Metanome-Companion PBx linkup. More

> PetMed's sales fall but profit margins expand on rising demand for pricier products. Story

> Zoetis, IDEXX, Schein among animal health scene-stealers at JP Morgan confab. Article

Biotech Research News

> Genetic error highlights a new approach to Fragile X syndrome. Report

> Microbiome research opens a new pathway for autoimmune disease. Article

> Tracking tech illuminates T cells for immuno-oncology research. Item

> Michigan investigators finger ATDC gene for aggressive pancreatic cancer. Story

> Alzheimer's investigators open a new front in BACE1 war. More

Pharma Manufacturing News

> Actavis recalling 65,000 bottles of generic seizure drug. News

> FDA raises issues with another Apotex plant. Article

> India makes move to reduce reliance on Chinese APIs. Item

> Boehringer Ingelheim picks up contract work for Sanofi mAbs. News

> India's Piramal says it will snatch up university CDMO for its injectables skills. Report

Suggested Articles

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.

Janssen tapped Resolution Bioscience to develop a companion diagnostic for Zejula in patients with metastatic castration-resistant prostate cancer.